Registry Platform Gastric/Esophageal Cancer (SAPHIR)

Sponsor
iOMEDICO AG
Study ID
NCT04290806
Status
Recruiting
Apply to this trial

Conditions

  • Esophageal Adenocarcinoma
  • Esophageal Squamous Cell Carcinoma
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Routine care as per site standard — OTHER
    Physician's choice according to patient's needs. Routine care as per site standard.

Study Details

The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.

Key Dates

First listed
Mar 2, 2020
Start date
Dec 4, 2019
Status verified
Jan 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
1,900 participants (estimated)

Arms

  • Arm: ESCC
    250 patients with esophageal squamous cell carcinoma
  • Arm: GAC
    920 patients with gastric adenocarcinoma
  • Arm: GEJAC
    580 patients with gastroesophageal junction adenocarcinoma
  • Arm: EAC
    150 patients with esophageal adenocarcinoma

Primary Outcome Measure

Course of treatment (treatment reality) [ Time Frame: 2 years per patient ]

Central Contacts

Related Studies